Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Squamous Cell Carcinoma of Head and Neck 98Head and Neck Neoplasms 91Nasopharyngeal Carcinoma 53Thyroid Neoplasms 30Mouth Neoplasms 24Thyroid Cancer, Papillary 15Carcinoma, Squamous Cell 14Carcinoma, Non-Small-Cell Lung 14Oropharyngeal Neoplasms 13Neoplasm Metastasis 13Laryngeal Neoplasms 12Neoplasms 11Uterine Cervical Neoplasms 10Colorectal Neoplasms 10Breast Neoplasms 10Thyroid Nodule 8Thyroid Diseases 7Nasopharyngeal Neoplasms 7Melanoma 7Lung Neoplasms 7Hypopharyngeal Neoplasms 7Ovarian Neoplasms 6Triple Negative Breast Neoplasms 5Sarcoma 5Recurrence 5Esophageal Neoplasms 5Endometrial Neoplasms 5Carcinoma, Renal Cell 5Thyroid Carcinoma, Anaplastic 4Stomach Neoplasms 4

Interventions

Radiotherapy, Intensity-Modulated 1Immune Checkpoint Inhibitors 1Cisplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Nasopharyngeal Cancinoma (NPC) × Head & Neck × Clear all
NCT07238569 2025-11-20

Phase III Trial of EBV-DNA-Guided Adaptive Immunotherapy for Advanced Nasopharyngeal Carcinoma

Sun Yat-sen University

Phase 3 Not yet recruiting
516 enrolled
Head & Neck

Nasopharyngeal Cancinoma (NPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡